The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

By Weiner D.   Meltzer H.   Veinbergs I.   Donohue E.   Spalding T.   Smith T.   Mohell N.   Harvey S.   Lameh J.   Nash N.   Vanover K.   Olsson R.   Jayathilake K.   Lee M.   Levey A.   Hacksell U.   Burstein E.   Davis R.   Brann M.  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 207-216

Springer Publishing Company

Access to resources Recommend Favorite

Distribution of clozapine and desmethylclozapine between blood and brain in rats

By Weigmann H.   Hartter S.   Fischer V.   Dahmen N.   Hiemke C.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 253-256

Elsevier

Access to resources Recommend Favorite

In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A 2 synthetase, on eicosanoid production

By Oketani K.   Nagakura N.   Harada K.   Inoue T.  

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice

By Simon V.M.   Parra A.   Minarro J.   Arenas M.C.   Vinader-Caerols C.   Aguilar M.A.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 159-164

Elsevier

Access to resources Recommend Favorite

Comparison of the effects of clozapine, haloperidol, chlorpromazine and-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat

By Mobini S.   Chiang T.-J.   Ho M.-Y.   Bradshaw C. M.   Szabadi E.  

Psychopharmacology, Vol. 152, Iss. 1, 2000-09 ,pp. : 47-54

Springer Publishing Company

Access to resources Recommend Favorite